X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (8) 8
humans (8) 8
index medicus (8) 8
male (8) 8
double-blind method (7) 7
aged (6) 6
formoterol fumarate - administration & dosage (6) 6
middle aged (6) 6
pulmonary/respiratory (6) 6
tropanes - administration & dosage (6) 6
chronic obstructive pulmonary disease (5) 5
obstructive pulmonary-disease (5) 5
pulmonary disease, chronic obstructive - drug therapy (5) 5
respiratory system (5) 5
aclidinium bromide/formoterol fumarate (4) 4
adult (4) 4
drug combinations (4) 4
respiratory tract diseases (4) 4
treatment outcome (4) 4
aclidinium bromide (3) 3
administration, inhalation (3) 3
adrenergic beta-2 receptor agonists - administration & dosage (3) 3
bromide (3) 3
drug therapy, combination (3) 3
fixed-dose combination (3) 3
forced expiratory volume (3) 3
formoterol (3) 3
formoterol fumarate (3) 3
formoterol fumarate - adverse effects (3) 3
management (3) 3
medical research (3) 3
medicine, experimental (3) 3
pharmaceutical industry (3) 3
pulmonary and respiratory medicine (3) 3
pulmonary disease, chronic obstructive - physiopathology (3) 3
stem cells (3) 3
time factors (3) 3
tropanes - adverse effects (3) 3
6-mercaptopurine (2) 2
abridged index medicus (2) 2
aclidinium (2) 2
agonists (2) 2
anal fistula (2) 2
anal fistulas (2) 2
bronchodilation (2) 2
bronchodilator agents - administration & dosage (2) 2
bronchodilator agents - adverse effects (2) 2
bronchodilator agents - pharmacology (2) 2
care and treatment (2) 2
cell therapy (2) 2
clinical remission (2) 2
clinical trials (2) 2
clinical-trials (2) 2
combined remission (2) 2
copd (2) 2
crohn disease - complications (2) 2
disease progression (2) 2
double-blind (2) 2
drug therapy (2) 2
dyspnea (2) 2
dyspnea - physiopathology (2) 2
efficacy (2) 2
europe (2) 2
exacerbations (2) 2
fistula (2) 2
fluticasone (2) 2
health status (2) 2
hospitals (2) 2
israel (2) 2
laboratories (2) 2
lung diseases, obstructive (2) 2
metronidazole (2) 2
muscarinic antagonists - administration & dosage (2) 2
pulmonary disease, chronic obstructive - diagnosis (2) 2
rectal fistula - etiology (2) 2
rectal fistula - surgery (2) 2
remission (2) 2
research (2) 2
safety (2) 2
smooth muscle (2) 2
tiotropium (2) 2
transplantation, homologous (2) 2
trial (2) 2
accord copd (1) 1
activity index (1) 1
adipose tissue (1) 1
adipose tissue - cytology (1) 1
adrenergic beta-2 receptor agonists - adverse effects (1) 1
adrenergic beta-2 receptor agonists - pharmacology (1) 1
analysis (1) 1
anticholesteremic agents - administration & dosage (1) 1
area under curve (1) 1
australia (1) 1
biological availability (1) 1
bromide/formoterol fumarate (1) 1
bronchodilator agents - pharmacokinetics (1) 1
bronchodilators (1) 1
cardiac & cardiovascular systems (1) 1
ciprofloxacin (1) 1
clinical trial (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10051, pp. 1281 - 1290
Journal Article
Respiratory research, ISSN 1465-9921, 2014, Volume 15, Issue 1, pp. 123 - 123
Background: Combining two long-acting bronchodilators with complementary mechanisms of action may provide treatment benefits to patients with chronic... 
Formoterol | Dyspnea | Health status | Lung function | Aclidinium | COPD | MODERATE | HYPERINFLATION | BRONCHODILATION | MAINTENANCE | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | TIOTROPIUM | BROMIDE | ACCORD COPD | FLUTICASONE | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | North America | Recovery of Function | Forced Expiratory Volume | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Female | Bronchodilator Agents - adverse effects | Tropanes - administration & dosage | Pulmonary Disease, Chronic Obstructive - diagnosis | Tropanes - adverse effects | Dry Powder Inhalers | Double-Blind Method | Drug Administration Schedule | Formoterol Fumarate - adverse effects | Administration, Inhalation | Treatment Outcome | Dyspnea - physiopathology | Lung - physiopathology | New Zealand | Muscarinic Antagonists - administration & dosage | Lung - drug effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Dyspnea - drug therapy | Aged | Australia | Health Status | Drug Combinations | Formoterol Fumarate - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Medicine, Experimental | Pharmaceutical industry | Medical research | Studies | Heart attacks | Laboratories | Smooth muscle | Chronic obstructive pulmonary disease | Drug therapy | Research
Journal Article
Journal Article
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2017, Volume 125, pp. 39 - 48
Abstract Introduction Aclidinium bromide/formoterol fumarate (AB/FF) 400/12 μg efficacy and safety was demonstrated in two 6-month Phase III studies (AUGMENT... 
Pulmonary/Respiratory | Formoterol | Clinical trial | Combination therapy | Aclidinium | COPD | MEDICATION | CARDIAC & CARDIOVASCULAR SYSTEMS | PERSISTENCE | AGONISTS | MULTIPLE | TRIAL | REFILL ADHERENCE | ACLIDINIUM BROMIDE/FORMOTEROL FUMARATE | RESPIRATORY SYSTEM | TIOTROPIUM | Forced Expiratory Volume - drug effects | Outcome Assessment (Health Care) | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Adrenergic beta-2 Receptor Agonists - pharmacology | Muscarinic Antagonists - pharmacology | Female | Drug Therapy, Combination | Tropanes - administration & dosage | Tropanes - adverse effects | Double-Blind Method | Formoterol Fumarate - pharmacology | Tropanes - pharmacology | Formoterol Fumarate - adverse effects | Administration, Inhalation | Bronchodilator Agents - pharmacology | Dyspnea - physiopathology | Disease Progression | Muscarinic Antagonists - administration & dosage | Adrenergic beta-2 Receptor Agonists - administration & dosage | Aged | Health Status | Formoterol Fumarate - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Clinical trials | Medicine, Experimental | Medical research | Lung diseases, Obstructive | Care and treatment | Drug therapy, Combination | Urinary tract infections | Respiratory agents | Dosage and administration | Bronchodilation | Effectiveness | Compliance | Lung diseases | Smooth muscle | Rhinopharyngitis | Infections | Urinary tract | Disease control | Patients | Incidence | Laboratory tests | Respiratory tract | Randomization | Dyspnea | Obstructive lung disease | Respiratory tract diseases | Chronic obstructive pulmonary disease | Safety | Respiration | Drug dosages
Journal Article
by Panés, Julián and García-Olmo, Damián and van Assche, Gert and Colombel, Jean Frederic and Reinisch, Walter and Baumgart, Daniel C and Dignass, Axel and Nachury, Maria and Ferrante, Marc and Kazemi-Shirazi, Lili and Grimaud, Jean C and de la Portilla, Fernando and Goldin, Eran and Richard, Marie Paule and Diez, Mary Carmen and Tagarro, Ignacio and Leselbaum, Anne and Danese, Silvio and Stift, Anton and Tschmelitsch, J. rg and Mrak, Karl and Tilg, Herbert and Kroberger, Irmgard and D'Hoore, Ané and de Looze, Danny and Baert, Filip and Pattyn, Paul and Zerbib, Philippe and Zerbib, Frank and Viennot, Stéphanie and Dupas, Jean-Louis and Orsoni, Pierre-Charles and Hebuterne, Xavier and Rahili, Amine and Allez, Matthieu and Panis, Yves and Reinshagen, Max and Scherer, Roland and Sturm, Aneas and Kruis, Wolfgang and Duek, Daniel-Simon and Waterman, Matti and Lahat-Zok, Adi and Zmora, Oded and Tulchinsky, Hagit and Edden, Yair and Spinelli, Antonino and Annese, Vito and Angriman, Imerio and Riegler, Gabriele and Selvaggi, Francesco and Oldenburg, Bas and Gilissen, Lennard and van Montfort, Gust and Lowenberg, Mark and Bemelman, Aianus Willem and Almenara, Raúl and Martín Arranz, María Dolores and García-Arranz, Mariano and Pérez Gisbert, Javier and Palasí, Rosana and Samsó, Carlos Taxonera and Herrera Justiniano, Jose Manuel and Rada, Ricardo and Butrón, M. Teresa and López, Daniel Carpio and López-Sanromán, Antonio and Hinojosa de Val, Joaquín and Solana, Amparo and González Argenté, F. Xavier and Pastor, Carlos and Guadalajara, Hector and ADMIRE CD Study Grp Collaborat and ADMIRE CD Study Group Collaborators
Gastroenterology, ISSN 0016-5085, 2018, Volume 154, Issue 5, pp. 1334 - 1342.e4
Journal Article
by Panés, Julián and García-Olmo, Damián and Van Assche, Gert and Colombel, Jean Frederic and Colombel, Jean F and Reinisch, Walter and Baumgart, Daniel C and Dignass, Axel and Nachury, Maria and Ferrante, Marc and Kazemi-Shirazi, Lili and Grimaud, Jean C and de la Portilla, Fernando and Goldin, Eran and Richard, Marie Paule and Diez, Mary Carmen and Tagarro, Ignacio and Leselbaum, Anne and Danese, Silvio and Stift, Anton and Tschmelitsch, Jörg and Mrak, Karl and Tilg, Herbert and Kroberger, Irmgard and D’Hoore, André and De Looze, Danny and Baert, Filip and Pattyn, Paul and Zerbib, Philippe and Zerbib, Frank and Viennot, Stéphanie and Dupas, Jean-Louis and Orsoni, Pierre-Charles and Hebuterne, Xavier and Rahili, Amine and Allez, Matthieu and Panis, Yves and Reinshagen, Max and Scherer, Roland and Sturm, Andreas and Kruis, Wolfgang and Duek, Daniel-Simon and Waterman, Matti and Lahat-Zok, Adi and Zmora, Oded and Tulchinsky, Hagit and Edden, Yair and Spinelli, Antonino and Annese, Vito and Angriman, Imerio and Riegler, Gabriele and Selvaggi, Francesco and Oldenburg, Bas and Gilissen, Lennard and Van Montfort, Gust and Lowenberg, Mark and Bemelman, Adrianus Willem and Almenara, Raúl and Martín Arranz, María Dolores and García-Arranz, Mariano and Pérez Gisbert, Javier and Palasí, Rosana and Samsó, Carlos Taxonera and Herrera Justiniano, Jose Manuel and Rada, Ricardo and Butrón, Mª Teresa and López, Daniel Carpio and López-Sanromán, Antonio and Hinojosa de Val, Joaquín and Solana, Amparo and González Argenté, F. Xavier and Pastor, Carlos and Guadalajara, Hector
Gastroenterology, ISSN 0016-5085, 04/2018, Volume 154, Issue 5, pp. 1334 - 1342.e4
Therapies for perianal fistulas in patients with Crohn’s disease are often ineffective in producing long-term healing. We performed a randomized... 
Combined Remission | Anal Fistula | Cell Therapy | Clinical Remission
Journal Article
Pituitary, ISSN 1386-341X, 5/2000, Volume 2, Issue 4, pp. 269 - 276
Objective: To determine the effects of the new somatostatin analogue, lanreotide, in its prolonged released form (PR), in patients with acromegaly.Design:... 
Medicine & Public Health | Diabetes | Neurosurgery | Medicine, Experimental | Medical research | Analysis
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.